MedCap AB (publ)
F:61MA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MedCap AB (publ)
F:61MA
|
SE |
|
Forever Entertainment SA
F:8FE
|
PL |
|
P
|
Pakistan Cables Ltd
KAR:PCAL
|
PK |
|
F
|
FineTek Co Ltd
TPEX:4549
|
TW |
|
Adavale Resources Ltd
ASX:ADD
|
AU |
Wall St Price Targets
61MA Price Targets Summary
MedCap AB (publ)
According to Wall Street analysts, the average 1-year price target for 61MA is 61.6 EUR with a low forecast of 59.09 EUR and a high forecast of 65.4 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 61MA's stock price target?
Price Target
61.6
EUR
According to Wall Street analysts, the average 1-year price target for 61MA is 61.6 EUR with a low forecast of 59.09 EUR and a high forecast of 65.4 EUR.
What is the Revenue forecast for MedCap AB (publ)?
Projected CAGR
9%
Over the last 7 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for MedCap AB (publ)?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for MedCap AB (publ)?
Projected CAGR
15%
Over the last 7 years, the compound annual growth rate for Operating Income has been 33%. The projected CAGR for the next 3 years is 15%.
What is the Pre-Tax Income forecast for MedCap AB (publ)?
Projected CAGR
20%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 33%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for MedCap AB (publ)?
Projected CAGR
20%
Over the last 7 years, the compound annual growth rate for Net Income has been 132%. The projected CAGR for the next 3 years is 20%.
